Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $126.28 million. The enterprise value is $47.57 million.
Important Dates
The last earnings date was Wednesday, March 5, 2025, after market close.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 51.33 million shares outstanding. The number of shares has increased by 3.10% in one year.
Current Share Class | 51.33M |
Shares Outstanding | 51.33M |
Shares Change (YoY) | +3.10% |
Shares Change (QoQ) | +0.91% |
Owned by Insiders (%) | 20.21% |
Owned by Institutions (%) | 36.17% |
Float | 31.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.60 |
Forward PS | 1.61 |
PB Ratio | 1.48 |
P/TBV Ratio | 1.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.60 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.46.
Current Ratio | 9.04 |
Quick Ratio | 8.48 |
Debt / Equity | 0.46 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.84 |
Financial Efficiency
Return on equity (ROE) is -49.59% and return on invested capital (ROIC) is -22.28%.
Return on Equity (ROE) | -49.59% |
Return on Assets (ROA) | -20.41% |
Return on Invested Capital (ROIC) | -22.28% |
Return on Capital Employed (ROCE) | -39.67% |
Revenue Per Employee | $369,750 |
Profits Per Employee | -$238,458 |
Employee Count | 216 |
Asset Turnover | 0.52 |
Inventory Turnover | 1.63 |
Taxes
In the past 12 months, Sight Sciences has paid $236,000 in taxes.
Income Tax | 236,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.77% in the last 52 weeks. The beta is 2.51, so Sight Sciences's price volatility has been higher than the market average.
Beta (5Y) | 2.51 |
52-Week Price Change | -50.77% |
50-Day Moving Average | 2.73 |
200-Day Moving Average | 4.87 |
Relative Strength Index (RSI) | 44.55 |
Average Volume (20 Days) | 294,850 |
Short Selling Information
The latest short interest is 1.91 million, so 3.73% of the outstanding shares have been sold short.
Short Interest | 1.91M |
Short Previous Month | 1.56M |
Short % of Shares Out | 3.73% |
Short % of Float | 6.08% |
Short Ratio (days to cover) | 5.35 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $79.87 million and -$51.51 million in losses. Loss per share was -$1.03.
Revenue | 79.87M |
Gross Profit | 68.29M |
Operating Income | -50.53M |
Pretax Income | -52.20M |
Net Income | -51.51M |
EBITDA | -49.82M |
EBIT | -50.53M |
Loss Per Share | -$1.03 |
Full Income Statement Balance Sheet
The company has $120.36 million in cash and $40.36 million in debt, giving a net cash position of $80.00 million or $1.56 per share.
Cash & Cash Equivalents | 120.36M |
Total Debt | 40.36M |
Net Cash | 80.00M |
Net Cash Per Share | $1.56 |
Equity (Book Value) | 87.52M |
Book Value Per Share | 1.72 |
Working Capital | 124.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$22.35 million and capital expenditures -$385,000, giving a free cash flow of -$22.74 million.
Operating Cash Flow | -22.35M |
Capital Expenditures | -385,000 |
Free Cash Flow | -22.74M |
FCF Per Share | -$0.44 |
Full Cash Flow Statement Margins
Gross margin is 85.50%, with operating and profit margins of -63.27% and -64.49%.
Gross Margin | 85.50% |
Operating Margin | -63.27% |
Pretax Margin | -64.20% |
Profit Margin | -64.49% |
EBITDA Margin | -62.38% |
EBIT Margin | -63.27% |
FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.10% |
Shareholder Yield | n/a |
Earnings Yield | -40.38% |
FCF Yield | -17.82% |
Analyst Forecast
The average price target for Sight Sciences is $3.83, which is 55.69% higher than the current price. The consensus rating is "Buy".
Price Target | $3.83 |
Price Target Difference | 55.69% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 0.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.01 |
Piotroski F-Score | 3 |